learning and resources

Browse by Subject

Best Practices | Clinical Readiness & Education | Disease Fact Sheet | Disease Modeling & Drug Discovery | Educator Resource | Foresight & Guidance | Future of the Field
Guidelines | Open-Access Webinar | Patient Resource | Podcast | Public Policy | Regulatory Policy | Standards | Stem Cell Reports | Webinar

View All Resources

Featured Resources

Guidelines for Stem Cell Research and Clinical Translation

Guidelines for Stem Cell Research and Clinical Translation

Read more →

Standards for Human Stem Cell Use in Research

Standards for Human Stem Cell Use in Research

Read more →

Best Practices for the Development of Pluripotent Stem Cell-Derived Therapies

Best Practices for the Development of Pluripotent Stem Cell-Derived Therapies

Read more →

The ISSCR Guide to Stem Cell Treatments

The ISSCR Guide to Stem Cell Treatments

Read more →

Keith Alm 4/29/26 Keith Alm 4/29/26

Guidelines for Stem Cell Research and Clinical Translation

Keith Alm 4/29/26 Keith Alm 4/29/26

Standards for Human Stem Cell Use in Research

Keith Alm 4/29/26 Keith Alm 4/29/26

Best Practices for the Development of Pluripotent Stem Cell-Derived Therapies

Keith Alm 4/29/26 Keith Alm 4/29/26

The ISSCR Guide to Stem Cell Treatments

Keith Alm 4/22/26 Keith Alm 4/22/26

Practical Advice for Physicians and Ethics / Institutional Review Committees

Keith Alm 4/22/26 Keith Alm 4/22/26

Informed Consent Standard for Human Fetal Tissue Donation for Research

Keith Alm 4/22/26 Keith Alm 4/22/26

Informed Consent Standard for Stem Cell-Based Interventions

Keith Alm 4/22/26 Keith Alm 4/22/26

Standards for Human Stem Cell Use in Research

Keith Alm 4/22/26 Keith Alm 4/22/26

Best Practices for the Development of PSC-Based Therapies: An Updated Draft

Keith Alm 4/22/26 Keith Alm 4/22/26

ISSCR Embryo Models Working Group: Summary of Findings and Recommendations

Keith Alm 9/1/25 Keith Alm 9/1/25

The ISSCR Responds to FDA’s Draft Guidance on Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing

Keith Alm 9/1/25 Keith Alm 9/1/25

The ISSCR Urges Continued NIH Investment in Human Embryonic Stem Cell Research to Sustain Scientific Progress and Therapeutic Innovation

Keith Alm 9/1/25 Keith Alm 9/1/25

ISSCR Offers Recommendations on Risk Mitigation in Advancing Stem Cell Therapies

Keith Alm 9/1/25 Keith Alm 9/1/25

The ISSCR Provides Comments on FNIH’s Accelerating Medicines Partnership Cell-Based Therapy Initiative

Keith Alm 9/1/25 Keith Alm 9/1/25

The ISSCR Provides Comments on FDA’s Draft Guidance for Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products

Keith Alm 9/1/25 Keith Alm 9/1/25

The ISSCR Provides Comments on FDA’s Draft Guidance for Potency Assurance for Cellular and Gene Therapy Products

Keith Alm 9/1/25 Keith Alm 9/1/25

ISSCR Members Hold First Scientific Advice Meeting with the U.K.’s Medicines and Healthcare products Regulatory Agency

Keith Alm 9/1/25 Keith Alm 9/1/25

ISSCR Holds First Academia Briefing Meeting with the European Medicines Agency

Keith Alm 9/1/25 Keith Alm 9/1/25

The ISSCR Responds to FDA’s Draft Guidance on Safety Testing of Human Allogeneic Cells Expanded for Use in Cell-Based Medical Products

Keith Alm 9/1/25 Keith Alm 9/1/25

The ISSCR Responds to ICH’s Q1 Guideline on Stability Testing of Drug Substances and Drug Products